SFPIA
LRMR icon

Stevens First Principles Investment Advisors’s Larimar Therapeutics LRMR Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-25
Closed -$10K – 218
2015
Q2 		$10K Buy
+25
New +$10.5K 0.01% 196

Other funds holding LRMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Stevens First Principles Investment Advisors's LRMR Position: Q3 2015 in Review

Stevens First Principles Investment Advisors sold out of Larimar Therapeutics (LRMR) in Q3 2015, closing a stake of 25 shares — an estimated $10K sold.

Stevens First Principles Investment Advisors first reported a position in LRMR in Q2 2015 and held it in 1 quarter. The position peaked at $10K in Q2 2015. 96 funds tracked by Wall St. Rank hold LRMR as of Q3 2015.

  • Stevens First Principles Investment Advisors reported no remaining Larimar Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 25 Larimar Therapeutics shares in Q3 2015, an estimated $10K.
  • Stevens First Principles Investment Advisors first reported a position in Larimar Therapeutics in Q2 2015 and held it in 1 quarter.
  • Stevens First Principles Investment Advisors's Larimar Therapeutics position peaked at $10K in Q2 2015.
  • 96 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2015.

Based on Stevens First Principles Investment Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.